Patents by Inventor Martin B. Slade

Martin B. Slade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5389526
    Abstract: The present invention relates generally to the fields of molecular biology and the production of recombinant protein using cellular slime moulds of the genus Dictyostelium. Most particularly, the present invention relates to novel strains of the genus Dictyostelium, recombinant plasmids for use with strains of the genus Dictyostelium, and polypeptides which facilitate the extrachromosomal replication of such plasmids in strains of the genus Dictyostelium. In particular, the present invention provides a polypeptide which facilitates the extrachromosomal replication of a recombinant plasmid in Dictyostelium spp in which the recombinant plasmid includes an origin of replication derived from a Ddp2-like plasmid but which lacks functional genes for extrachromosomal replication in wild type Dictyostelium spp.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: February 14, 1995
    Inventors: Martin B. Slade, Andy C. M. Chang, Keith L. Williams
  • Patent number: 4582811
    Abstract: A diagnostic aid for use in detecting occult blood in faeces is described. The aid consists of a carrier which is coated with specific monoclonal anti-human antibody and, which upon contact with a faecal liquid suspension, specifically absorbs human hemoglobin. A chemical or an enzymatic assay may then be used to detect the hemoglobin.
    Type: Grant
    Filed: February 1, 1984
    Date of Patent: April 15, 1986
    Assignee: Australian Monoclonal Development Pty. Ltd.
    Inventors: Alessandra Pucci, Antony M. Smithyman, Martin B. Slade, Peter W. French, Gene Wijffels